2018
DOI: 10.1016/j.atherosclerosis.2018.06.229
|View full text |Cite
|
Sign up to set email alerts
|

One year follow-up in 45 patients with heterozygous familial hypercholesterolemia (HEHF) after treatment with alirocumab: a report from a tertiary care center in Seville, Spain

Help me understand this report

This publication either has no citations yet, or we are still processing them

Set email alert for when this publication receives citations?

See others like this or search for similar articles